| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 10/09/2008 | WO2008005998A3 Centimeter-scale, integrated diagnostics incubator for biological culturing |
| 10/09/2008 | WO2007123737A3 Methods and compositions for localized secretion of anti-ctla-4 antibodies |
| 10/09/2008 | WO2007112001A3 Compositions and methods for treating myocardial infarction |
| 10/09/2008 | WO2007095729A8 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 10/09/2008 | WO2007089367A3 Use hedgehog kinase antagonists to inhibit hedgehog signaling and to treat cancer |
| 10/09/2008 | US20080250533 Transgenic plant with enhanced expression of UDP-glucose dehydrogenase and hyaluronan synthase; for improving nutrient quality of animal feeds |
| 10/09/2008 | US20080250528 Rice Glutelin Gene Promoters |
| 10/09/2008 | US20080250524 Soybean cultivar 6449315 |
| 10/09/2008 | US20080250523 Transgenic seeds for propagation of disease, insect, drought and herbicide resistant plants with enhanced fatty acid and carbohydrate metabolism; improving nutrient quality of crops |
| 10/09/2008 | US20080250522 Soybean cultivar 6012078 |
| 10/09/2008 | US20080250521 Transgenic seeds for propagation of disease, insect, drought and herbicide resistant plants with enhanced fatty acid and carbohydrate metabolism; improving nutrient quality of crops |
| 10/09/2008 | US20080250515 Polypeptide localization signal for enhancing bioavailability of drugs |
| 10/09/2008 | US20080250514 Expression Systems Using Mammalian Beta-Actin Promoter |
| 10/09/2008 | US20080250511 Nucleotide sequences for use as screening tools in diagnosis of anxiety and/or depressive disorder |
| 10/09/2008 | US20080249624 Method for the Production of Intervertebral Disk Cell Transplants and Their Use as Transplantation Material |
| 10/09/2008 | US20080249293 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 10/09/2008 | US20080249288 Recombinantly preparing antibody fusion for targeting and/or treating metabolic disorders |
| 10/09/2008 | US20080249176 Methods and Compositions for the Treatment of Myocardial Conditions |
| 10/09/2008 | US20080249083 isolated nucleic acids coding for novel glutaminyl-peptide cyclotransferase-like proteins (QPCTLs); isoenzymes; useful for the discovery of new therapeutic agents, for measuring cyclase activity; Alzheimer's disease, Familial British Dementia, Familial Danish Dementia, Down Syndrome, Huntington's disease |
| 10/09/2008 | US20080249081 Compounds for the treatment of pain and screening methods therefor |
| 10/09/2008 | US20080249067 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP) |
| 10/09/2008 | US20080249059 contacting islet cell with an agent that increases intracellular levels of 0-acetyl-ADP-ribose, resulting in cellular depolarization and/or Ca2+ entry which modulates insulin secretion; puromycin; agent which inhibits sirtuin activity thereby preventing islet cell death; nicotinamide |
| 10/09/2008 | US20080249057 Protein kinase C as a target for the treatment of respiratory syncytial virus |
| 10/09/2008 | US20080249056 agents that affect the activity and/or expression of CXCL16 can be used to alter the uptake of D-type CpG oligodeoxynucleotides; to decrease an immune response; antagonist of ADAM-10 is GW280264X, G1254023X or GM6001 |
| 10/09/2008 | US20080249049 for the delivery of nucleic acid to target cells or tissues; poly(amino acid), polysaccharide, polyester, polyether, polyurethane or vinyl polymer |
| 10/09/2008 | US20080249042 cultured prokaryotic or eukaryotic cell transformed or transfected with expression construct; vectors; treating retinal disease or blindness |
| 10/09/2008 | US20080249036 Antagonist Against Tolerance to Anticancer Drugs |
| 10/09/2008 | US20080249027 Heptapeptide having the sequence of CHEASQC; Multiple Sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis |
| 10/09/2008 | US20080249026 PEPTIDES AND THEIR UTILITY IN MODULATION OF BEHAVIOR OF CELLS EXPRESSING alpha3beta1 INTEGRINS |
| 10/09/2008 | US20080249025 Peptide fragments of p21; antiproliferative agents |
| 10/09/2008 | US20080249024 Peptides facilitating or inhibiting a nterograde transport |
| 10/09/2008 | US20080249012 INCREASING LIFE SPAN BY MODULATION OF Smek |
| 10/09/2008 | US20080249010 Method Of Inducing Apoptosis In Lymphoid Cells |
| 10/09/2008 | US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions |
| 10/09/2008 | US20080248997 Modified g-protein coupled receptor for identifying modulators of taste preception; artificial sweeteners |
| 10/09/2008 | US20080248996 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 10/09/2008 | US20080248994 Methods of using deacetylase inhibitors to promote cell differentiation and regeneration |
| 10/09/2008 | US20080248959 Polypeptide with amino acid sequence including exogenous glycosylate sequence; libraries |
| 10/09/2008 | US20080248576 Genetic Inhibition of double-stranded RNA |
| 10/09/2008 | US20080248574 Therapeutic polypeptide comprising cell entry doman for use in treatment of cell proliferative disorders; enhancing metastaic tumor sensitivity to oxidative stress |
| 10/09/2008 | US20080248573 Nutrient broth comprising calves blood protein-free hemodialysate for enhancing efficay and success of intrauterine insemination; in vito fertilization and reproductive medicne |
| 10/09/2008 | US20080248572 Bioreactor Surfaces |
| 10/09/2008 | US20080248571 Method of Production of Artificial Skin |
| 10/09/2008 | US20080248570 Culturing hepatic cells in serum free nutrient broth comprising hyaluronan, growth factors and hormones |
| 10/09/2008 | US20080248569 Self-assembling peptide amphiphiles for tissue engineering |
| 10/09/2008 | US20080248568 Propagating pluripotent cells in nutrient broth, activating notch signaling, recovering nervous system tissues; tissue engineering and regenerative medicine |
| 10/09/2008 | US20080248567 Propagating self-renewing pluripotent progenitor cells in nutrient broth conditioned with WNTexpressing cells; tissue engineering; regenerative medicine |
| 10/09/2008 | US20080248566 Matriptase, a serine protease and its applications |
| 10/09/2008 | US20080248565 Isolated phospholipid-protein particles |
| 10/09/2008 | US20080248564 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 10/09/2008 | US20080248548 Regulating conformation and biological activity via switch control ligand-pocket interaction; drug screening; bioinformatics |
| 10/09/2008 | US20080248545 Modified cytochrome p450 for use as tool in identifying carcinogenic agents |
| 10/09/2008 | US20080248531 Preparation of fully human antibodies |
| 10/09/2008 | US20080248529 Expression vector comprising nucleotide sequences coding lymphocyte surface protein specific immunoglobulin for use in treatment of cell proliferative, inflammatory and autoimmune diseases |
| 10/09/2008 | US20080248526 Preparing dickkopf homolog 1 ( Dkk1 Protein) in transgenic cells; identifying modulators for treatment and prevention of oncogenesis |
| 10/09/2008 | US20080248524 AMP Deaminase Originating Streptomyces And Utilization Thereof |
| 10/09/2008 | US20080248523 Utilisation of Constructs Comprising Recombination Sequence Motifs for Enhancing Gene Expression in Moss |
| 10/09/2008 | US20080248515 Optimizing culture medium for CD34<+> hematopoietic cell expansion |
| 10/09/2008 | US20080248499 Using cross sectional shaped flow channel to isolate/recover cancer cell from bodily fluid |
| 10/09/2008 | US20080248495 Protease Activated Receptor (PAR) activating peptide for use as screening tool in identifying modulators for treatment of thrombosis |
| 10/09/2008 | US20080248494 Diagnosing menopause via follicle stimulating hormone specfic immunoglobulins |
| 10/09/2008 | US20080248477 Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |
| 10/09/2008 | US20080248475 Methods and Compositions for Modulating Gluconeogenesis Using PGC-1 |
| 10/09/2008 | US20080248458 Purification, Characterization and Reconstitution of a Ubiquitin E3 Ligase |
| 10/09/2008 | US20080248188 maize starch,has an increased phosphate content and/or a modified phosphorylation pattern and/or an increased final viscosity in an RVA profile and/or a reduced peak temperature in DSC analysis and/or an increased gel strength in texture analysis compared with starch from non-genetically modified plant |
| 10/09/2008 | US20080248084 Method of treating acute dysfunction of cardiac muscle |
| 10/09/2008 | US20080248082 Deliver platelet rich plasma, sodium bicarbonate, calcium gluconate, choline chloride buffers, thrombin, collagen, epinephrine releasate, via catheter; coat suture, stent, screw, plate implants with plasma |
| 10/09/2008 | US20080248081 Method of treating chronic dysfunction of cardiac muscle |
| 10/09/2008 | US20080248080 Decelluarlized Tissue Engineered Constructs and Tissues |
| 10/09/2008 | US20080248078 Controller for receiving information and feedback information and an output, a pressure/flow loop subsystem: a specimen holder, an external flow loop system capable of adjusting a diameter of a specimen in accordance with control signals |
| 10/09/2008 | US20080248069 Dosage Forms of Active Ingredients Containing Hydroxystilbene for Treating Menopausal Complaints |
| 10/09/2008 | US20080248068 Use of Flagellin as an Adjuvant for Vaccine |
| 10/09/2008 | US20080248064 Localization and Characterization of Flavivirus Envelope Gylcoprotein Cross-Reactive Epitopes and Methods for their Use |
| 10/09/2008 | US20080248054 Regulation of Mink in Thymocytes and T Lymphocytes |
| 10/09/2008 | US20080248046 Death domain containing receptor 5 |
| 10/09/2008 | US20080248045 Polypeptides having a triggering nk activity and biological applications |
| 10/09/2008 | US20080248043 Antibodies to SARS coronavirus |
| 10/09/2008 | US20080248042 Monoclonal antibody cross-reactive against infective agent causing a B-cell expansion and IgG-Fc |
| 10/09/2008 | US20080248040 Nucleotide sequences coding membrane protein segments for use in identifying modulators for prevention and treatment of epilepsy, cancer, pain and sleep disorders |
| 10/09/2008 | US20080248031 Cell surface molecule mediating cell adhesion and signal transmission |
| 10/09/2008 | US20080248020 Variant lyase for use in treatment and prevention of cell proliferative disorders |
| 10/09/2008 | US20080248012 Modulator of adenosine triphosphate release from red blood cells; treating and preventing ischemic reperfusion injuries, cardiovascular and vasodilatory diseases |
| 10/09/2008 | US20080248011 Immunoglobulin for identifying cells expressing monocyte integral membrane proein (HIDE-1); inducing propagation of dendritic cell for use in treatment of autoimmune, tumor and organ rejection disorders |
| 10/09/2008 | US20080248009 Using antisense agents specific to apoptosis-associated nucleic acids to modulate apoptosis in transplanted tissues; treating cell proliferative disorders |
| 10/09/2008 | US20080248008 Transferase inhibitory mimetic for use in treatment and prevention of immunosuppressive, cell proliferative and autoimmune disorders |
| 10/09/2008 | US20080248007 Nucleotide sequences coding protein associated with immune response for use in identifying modulators for prevention and treatment of immunodeficiency, autoimmue and inflammatory disorders |
| 10/09/2008 | US20080248006 Propagating osteogenic or bone precursor cells in nutrient broth; tissue engineering and repair; regenerative medicine; treating and/or preventing bone disorders |
| 10/09/2008 | US20080248005 Isolation and Cultivation of Stem/Progenitor Cells From the Amniotic Membrane of Umbilical Cord and Uses of Cells Differentiated Therefrom |
| 10/09/2008 | US20080248004 Bone marrow and/or cord stem cell culture for use in treatment of nervous system disorders; tissue engineering and repair; regenerative medicine |
| 10/09/2008 | US20080248003 Methods and Compositions for Growing Adipose Stem Cells |
| 10/09/2008 | US20080248002 Cytokine induced killer cell populations for use in treatment of cell proliferative disordersl; tissue engineering and repair; tissue targeted therapy |
| 10/09/2008 | US20080248000 CD14 and CD34 expressing adult stem cell culture for use in treatment of vascular disorders; tissue engineering and repair; regenerative medicine |
| 10/09/2008 | US20080247998 Propagating mesenchymal stem cells into strip for use in treatment of heart defects; tissue engineering and repair; regenerative medicine |
| 10/09/2008 | US20080247990 Recombinant lymphocyte expressing CD16 receptor for use in targeting and destroying viral infection and tumor tissues |
| 10/09/2008 | US20080247944 Human monoclonal antibodies; encoded by nucleic acids; anticancer agents |
| 10/09/2008 | CA2682482A1 Methods of gene amplification and expression |
| 10/09/2008 | CA2682472A1 High expression clones of mammalian cells with fluorescent protein a or g |
| 10/09/2008 | CA2682199A1 Chloroplasts engineered to express pharmaceutical proteins in edible plants |
| 10/09/2008 | CA2682170A1 Antibodies with decreased deamidation profiles |
| 10/09/2008 | CA2682100A1 Transgenic animal models of disease |